Skip to main content
. 2021 Aug 9;21:773. doi: 10.1186/s12879-021-06507-8

Table 6.

Medical history and physical examination data about a probable or confirmed case of COVID-19

Main class Sub class Data element
Signs and symptoms at the time of admission General signs and symptoms Fever, chills, tiredness, muscle aches, headache, loss of smell or taste, eye congestion, dry mouth, other(s), please specify
Respiratory signs and symptoms Dry cough, sneezing, runny nose, dyspnea/tachypnea, constant pain or pressure in chest, nasal congestion, exudative pharyngitis, mucus or phlegm, hemoptysis, other(s), please specify
Digestive signs and symptoms Diarrhea, nausea or vomiting, loss of appetite, abdominal pain, constipation, other(s), please specify
Nervous signs and symptoms Fatigue, decreased consciousness, Glasgow coma scale/score (GCS), functional limb weakness, other(s), please specify
Cardiovascular signs and symptoms Orthopnea, ischemia, angina‏‏, arrhythmias, other(s), please specify
Others signs and symptoms Rash on skin, discoloration of fingers or toes, other(s), please specify
Review of systems at the time of admission Vital signs Pulse rate, respiratory rate, blood pressure, temperature, level of consciousness
Thorax Heart murmurs, wheezing, stridor, pleural friction rub, ventricular gallop, atrial gallop, other(s), please specify
Abdomen Tenderness, organomegaly, other(s), please specify
Limbs Edema, weak pulse, other(s), please specify
Height and weight Height, weight, BMI > 30
Other Others signs and symptoms, please specify, additional comment
Underlying conditions and comorbidity Cardiovascular diseases Hypertension, heart failure, arrhythmia, ischemic heart disease, other(s), please specify
Endocrine and metabolic diseases

Type 1 diabetes mellitus, Type 2 diabetes mellitus, unspecified diabetes mellitus

If yes, Had the patient’s diabetes be controlled?

Metabolic syndrome, other(s), please specify

Malignant neoplasms

Morphology, primary site, secondary site

If yes, Does the patient receive chemotherapy?

If yes, Does the patient receive radiotherapy?

Additional comment

Respiratory diseases Chronic obstructive pulmonary disease (COPD), bronchiectasis, interstitial lung disease (ILD), asthma, other(s), please specify
Immunodeficiency HIV/AIDS, congenital immunodeficiency disorders, other(s), please specify

The patient is being treated with corticosteroids or immunosuppressant medications

If yes, Name of medications used, medications dosage

Chronic neurological or neuromuscular diseases Cerebral palsy, paraplegia, hemiplegia, multiple sclerosis (MS), old cerebrovascular accident (CVA),other(s), please specify
Renal diseases Chronic kidney disease, end stage renal disease (ESRD), other(s), please specify
Liver diseases Liver failure, liver cirrhosis, hepatitis (A, B, C), other(s), please specify
Other important underlying conditions and comorbidity, Prematurity (infant), mental retardation, other important underlying conditions and comorbidity, please specify
Pregnancy, childbirth and the puerperium Pregnancy, gestational age
Childbirth in the last 6 weeks
Menopause Menopause, menopause age
Smoking, drugs abuse and alcohol Cigarettes, hookahs, alcohol, drug’s abuse, additional comment
Medications history Name of drug, drug dosage, additional comment
Previous history of COVID-19 History of COVID-19 Had a previous history of COVID-19, illness onset date, disease severity status (mild, moderate and severe), additional comment
History of COVID-19 vaccination History of COVID-19 vaccination, number of vaccine doses received, date of administration